Package 62135-176-60

{"route": ["ORAL"], "spl_id": "2526421a-bb2b-1e0b-e063-6394a90a42fc", "openfda": {"nui": ["N0000000160", "M0001335", "N0000175722"], "upc": ["0362135176600", "0362135176181"], "unii": ["MHJ80W9LRB"], "rxcui": ["312132"], "spl_set_id": ["db349233-9f09-471c-aeee-f91338d2ffe9"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Chartwell RX, LLC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "180 TABLET in 1 BOTTLE (62135-176-18)", "package_ndc": "62135-176-18", "marketing_start_date": "20220822"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (62135-176-60)", "package_ndc": "62135-176-60", "marketing_start_date": "20220822"}], "brand_name": "OXAPROZIN", "product_id": "62135-176_2526421a-bb2b-1e0b-e063-6394a90a42fc", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "62135-176", "generic_name": "OXAPROZIN", "labeler_name": "Chartwell RX, LLC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "OXAPROZIN", "active_ingredients": [{"name": "OXAPROZIN", "strength": "600 mg/1"}], "application_number": "ANDA075987", "marketing_category": "ANDA", "marketing_start_date": "20040902", "listing_expiration_date": "20261231"}